Data / Form D filings / Opko Health, Inc.
Opko Health, Inc.: Form D filings
Opko Health, Inc., a pharmaceuticals company in Miami, FL, filed 2 Form D notices with the SEC between 2009 and 2013. The latest, on February 15, 2013, reports $175 million sold of a $175 million offering to 105 investors.
Find out what Opko Health, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4400 Biscayne Blvd., Miami, FL, 33137
- Phone
- (305) 575-4100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 944809
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 15, 2013 | New notice | $175,000,000 | $175,000,000 | $0 | 105 | Jan 30, 2013 | sec.gov |
| Jun 3, 2009 | New notice | $31,000,000 | $31,000,000 | $0 | 7 | May 26, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard C. Pfenniger, Jr. | Director | |
| Alice Lin-Tsing C. Yu | Director | |
| Phillip Frost | Executive Officer, Director | |
| Jane H. Hsiao | Executive Officer, Director | |
| Juan F. Rodriguez | Executive Officer | |
| Thomas E. Beier | Director | |
| John A. Paganelli | Director | |
| Richard A. Lerner | Director | |
| Robert A. Baron | Director | |
| Steven D. Rubin | Executive Officer, Director | |
| Dmitry A. Kolosov | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Feb 11, 2013 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Opko Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.